Brain Navi Biotechnology
Brain Navi Biotechnology Co., Ltd., founded in 2015 and based in Taiwan's Hsinchu Biomedical Science Park, is a leading surgical robot company specializing in neurosurgical navigation systems. The company develops innovative medical devices like NaoTrac, an autonomous neurosurgical navigation robot that integrates AI, machine vision, and robotic precision to improve surgical accuracy, streamline procedures, and reduce learning curves. NaoTrac supports various neurosurgical procedures including brain tumor biopsy and deep brain stimulation, and has received regulatory clearances including FDA 510(k), CE Mark, and Taiwan FDA. Brain Navi collaborates with top doctors and researchers in Taiwan, leveraging local R&D and manufacturing strengths to deliver cutting-edge technology with global expansion ambitions. The company has achieved significant milestones such as 100 surgeries with NaoTrac, multiple innovation awards, and international clinical adoption, positioning it as a key player in the medtech neurosurgery market.
Brain Navi Biotechnology
Brain Navi Biotechnology Co., Ltd., founded in 2015 and based in Taiwan's Hsinchu Biomedical Science Park, is a leading surgical robot company specializing in neurosurgical navigation systems. The company develops innovative medical devices like NaoTrac, an autonomous neurosurgical navigation robot that integrates AI, machine vision, and robotic precision to improve surgical accuracy, streamline procedures, and reduce learning curves. NaoTrac supports various neurosurgical procedures including brain tumor biopsy and deep brain stimulation, and has received regulatory clearances including FDA 510(k), CE Mark, and Taiwan FDA. Brain Navi collaborates with top doctors and researchers in Taiwan, leveraging local R&D and manufacturing strengths to deliver cutting-edge technology with global expansion ambitions. The company has achieved significant milestones such as 100 surgeries with NaoTrac, multiple innovation awards, and international clinical adoption, positioning it as a key player in the medtech neurosurgery market.